First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer. (Q35868423)
Jump to navigation
Jump to search
scientific article published on 4 February 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer. |
scientific article published on 4 February 2015 |
Statements
First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer (English)
Julian R Molina
Geoffrey I Shapiro
Katherine M Bell-McGuinn
Johanna Bendell
Susan S Pandya
Robert Millham
Gary Borzillo
Kristen J Pierce
Lixin Han
Brett E Houk
Jorge D Gallo
Maria Alsina
4 February 2015
1 reference